KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

LifeMD (LFMD) Change in Intangibles (2022 - 2024)

LifeMD filings provide 2 years of Change in Intangibles readings, the most recent being $1862.0 for Q3 2024.

On a quarterly basis, Change in Intangibles changed N/A to $1862.0 in Q3 2024 year-over-year; TTM through Dec 2024 was $1862.0, a N/A change, with the full-year FY2024 number at $3798.0, down 97.45% from a year prior.
Change in Intangibles hit $1862.0 in Q3 2024 for LifeMD, down from $4.0 million in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of $4.0 million in Q1 2022 to a low of $1862.0 in Q3 2024.